Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Comparison of the efficacy and safety of low molecular weight heparins for venous thromboembolism prophylaxis in medically ill patients.

Dooley C, Kaur R, Sobieraj DM.

Curr Med Res Opin. 2014 Mar;30(3):367-80. doi: 10.1185/03007995.2013.837818. Epub 2013 Nov 19. Review.

PMID:
23971722
2.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
3.

Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.

Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM.

Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28. Review.

PMID:
22744711
4.

Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.

Holzheimer RG.

Eur J Med Res. 2004 Apr 30;9(4):225-39. Review.

PMID:
15210403
5.

Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis.

Albertsen IE, Larsen TB, Rasmussen LH, Overvad TF, Lip GY.

Drugs. 2012 Sep 10;72(13):1755-64. doi: 10.2165/11635630-000000000-00000. Review.

PMID:
22876779
6.

Selecting an anticoagulant for recurrent venous thromboembolism in cancer.

Goodin S.

Am J Health Syst Pharm. 2005 Nov 15;62(22 Suppl 5):S10-3.

PMID:
16286363
7.

Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients.

Deitelzweig SB, Vanscoy GJ, Niccolai CS, Rihn TL.

Ann Pharmacother. 2003 Mar;37(3):402-11. Review.

PMID:
12639173
8.

Low-molecular-weight heparins in the treatment of deep-vein thrombosis.

Martineau P, Tawil N.

Ann Pharmacother. 1998 May;32(5):588-98, 601. Review.

PMID:
9606481
10.

Low molecular weight heparins for venous thromboembolism.

[No authors listed]

Drug Ther Bull. 1998 Apr;36(4):25-9. Review.

PMID:
9684414
11.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
12.

A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer.

Simonneau G, Laporte S, Mismetti P, Derlon A, Samii K, Samama CM, Bergman JF; FX140 Study Investigators.

J Thromb Haemost. 2006 Aug;4(8):1693-700. Epub 2006 Jun 21.

13.
14.

Meta-regression analysis to indirectly compare prophylaxis with dalteparin or enoxaparin in patients at high risk for venous thromboembolic events.

Dranitsaris G, Jelincic V, Choe Y.

Clin Appl Thromb Hemost. 2012 Jun;18(3):233-42. doi: 10.1177/1076029611426869. Epub 2012 Mar 2. Review.

PMID:
22387576
15.

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

Andras A, Sala Tenna A, Crawford F.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD002001. doi: 10.1002/14651858.CD002001.pub2. Review.

PMID:
23076894
16.

Safety and efficacy of low-molecular-weight heparins in prophylaxis of deep vein thrombosis in postoperative/ICU patients: A comparative study.

Saxena A, Mittal A, Arya SK, Malviya D, Srivastava U.

J Nat Sci Biol Med. 2013 Jan;4(1):197-200. doi: 10.4103/0976-9668.107290.

17.

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J.

Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.

18.

Comparative effectiveness of combined pharmacologic and mechanical thromboprophylaxis versus either method alone in major orthopedic surgery: a systematic review and meta-analysis.

Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM.

Pharmacotherapy. 2013 Mar;33(3):275-83. doi: 10.1002/phar.1206. Epub 2013 Feb 11. Review.

PMID:
23401017
19.

Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.

[No authors listed]

Prescrire Int. 2013 Apr;22(137):99-101, 103-4. Review.

PMID:
23662321
20.

Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.

Yoshida Rde A, Yoshida WB, Maffei FH, El Dib R, Nunes R, Rollo HA.

Ann Vasc Surg. 2013 Apr;27(3):355-69. doi: 10.1016/j.avsg.2012.06.010. Epub 2013 Jan 23. Review.

PMID:
23351997
Items per page

Supplemental Content

Write to the Help Desk